Literature DB >> 22882192

Molecular prognostic markers in gallbladder carcinoma.

Palepu Jagannath, Mark Callery.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22882192      PMCID： PMC3461381          DOI： 10.1111/j.1477-2574.2012.00530.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN： 1365-182X            Impact factor:   3.647


× No keyword cloud information.
  9 in total

1.  Tissue microarrays (TMAs) for high-throughput molecular pathology research.

Authors:  A Nocito; J Kononen; O P Kallioniemi; G Sauter
Journal:  Int J Cancer       Date:  2001-10-01       Impact factor: 7.396

2.  Cyclin D1 overexpression is a critical event in gallbladder carcinogenesis and independently predicts decreased survival for patients with gallbladder carcinoma.

Authors:  A M Hui; X Li; Y Z Shi; T Takayama; G Torzilli; M Makuuchi
Journal:  Clin Cancer Res       Date:  2000-11       Impact factor: 12.531

Review 3.  The role of the redox protein thioredoxin in cell growth and cancer.

Authors:  G Powis; D Mustacich; A Coon
Journal:  Free Radic Biol Med       Date:  2000-08       Impact factor: 7.376

4.  Nuclear expression of thioredoxin-1 in the invasion front is associated with outcome in patients with gallbladder carcinoma.

Authors:  Motoaki Nagano; Kinta Hatakeyama; Masahiro Kai; Hajime Nakamura; Junji Yodoi; Yujiro Asada; Kazuo Chijiiwa
Journal:  HPB (Oxford)       Date:  2012-06-08       Impact factor: 3.647

5.  Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival.

Authors:  Meri Varga; Peter Obrist; Stephan Schneeberger; Gilbert Mühlmann; Christina Felgel-Farnholz; Dominic Fong; Mathias Zitt; Thomas Brunhuber; Georg Schäfer; Guenther Gastl; Gilbert Spizzo
Journal:  Clin Cancer Res       Date:  2004-05-01       Impact factor: 12.531

6.  The thioredoxin-thioredoxin reductase system: over-expression in human cancer.

Authors:  David T Lincoln; Eman M Ali Emadi; Kathryn F Tonissen; Frank M Clarke
Journal:  Anticancer Res       Date:  2003 May-Jun       Impact factor: 2.480

7.  Gallbladder carcinoma: the role of p53 protein overexpression and Ki-67 antigen expression as prognostic markers.

Authors:  Luis A Hidalgo Grau; Josep M Badia; Carmen Admella Salvador; Teresa Soler Monsó; Josep Feliu Canaleta; Josep M Gubern Nogués; Javier Suñol Sala
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

8.  Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.

Authors:  Marco Gerlinger; Andrew J Rowan; Stuart Horswell; James Larkin; David Endesfelder; Eva Gronroos; Pierre Martinez; Nicholas Matthews; Aengus Stewart; Charles Swanton; M Math; Patrick Tarpey; Ignacio Varela; Benjamin Phillimore; Sharmin Begum; Neil Q McDonald; Adam Butler; David Jones; Keiran Raine; Calli Latimer; Claudio R Santos; Mahrokh Nohadani; Aron C Eklund; Bradley Spencer-Dene; Graham Clark; Lisa Pickering; Gordon Stamp; Martin Gore; Zoltan Szallasi; Julian Downward; P Andrew Futreal
Journal:  N Engl J Med       Date:  2012-03-08       Impact factor: 91.245

9.  RCAS1 as a tumour progression marker: an independent negative prognostic factor in gallbladder cancer.

Authors:  T Oshikiri; Y Hida; M Miyamoto; H Hashida; K Katoh; M Suzuoki; Y Nakakubo; K Hiraoka; T Shinohara; T Itoh; S Kondo; H Katoh
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.